Evidence map›Paper›PMID 22609946›Full record

ArticleEnvironmental health perspectives2012

Obesity is mediated by differential aryl hydrocarbon receptor signaling in mice fed a Western diet.

Joanna S Kerley-Hamilton, Heidi W Trask, Christian J A Ridley, Eric Dufour, Carol S Ringelberg, Nilufer Nurinova, Diandra Wong, Karen L Moodie, Samantha L Shipman, Jason H Moore and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Joanna S Kerley-HamiltonDartmouth-Hitchcock Medical Center, Lebanon, Norris Cotton Cancer Center, Lebanon, New Hampshire, USA.
Heidi W Trask
Christian J A Ridley
Eric Dufour
Carol S Ringelberg
Nilufer Nurinova
Diandra Wong
Karen L Moodie
Samantha L Shipman
Jason H Moore
Murray Korc
Nicholas W Shworak
Craig R Tomlinson
Dartmouth–Hitchcock Medical Center · USDartmouth College · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Quantitative Biology Research InstituteP20GM103534 · NIGMS · DARTMOUTH COLLEGE · PI AMOS, CHRISTOPHER I. · 2012 to 2016
$8.6M
Training Program for Quantitative Population Sciences in CancerR25CA134286 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA, TOSTESON, TOR D · 2009 to 2018
$3.0M
QUANTITATIVE BIOLOGY RESEARCH INSTITUTEP20RR024475 · NCRR · DARTMOUTH COLLEGE · PI MOORE, JASON H. · 2011 to 2011
$2.3M
3OST1 Deficiency and Cardiovascular DiseaseR01AG023590 · NIA · DARTMOUTH COLLEGE · PI SHWORAK, NICHOLAS W · 2005 to 2008
$985k
Role of fetal TCDD-activited AHR in adult heart diseaseR21ES013827 · NIEHS · UNIVERSITY OF CINCINNATI · PI TOMLINSON, CRAIG R · 2005 to 2008
$417k
Vevo 770 for Ultrasound BiomicroscopyS10RR023436 · NCRR · DARTMOUTH COLLEGE · PI SHWORAK, NICHOLAS W · 2007 to 2007
$352k
NCI NIH HHS P30 CA023108NCI NIH HHS P30CA023108NCI NIH HHS R25 CA134286NCI NIH HHS R25CA134286NCRR NIH HHS 5P20RR024475-02NCRR NIH HHS P20 RR024475NCRR NIH HHS S10 RR023436NIA NIH HHS R01 AG023590NIEHS NIH HHS R21 ES013827NIEHS NIH HHS R21ES013827NIGMS NIH HHS 8P20GM103534-02NIGMS NIH HHS P20 GM103534
6 · The paper itself

Abstract

backgroundObesity is a growing worldwide problem with genetic and environmental causes, and it is an underlying basis for many diseases. Studies have shown that the toxicant-activated aryl hydrocarbon receptor (AHR) may disrupt fat metabolism and contribute to obesity. The AHR is a nuclear receptor/transcription factor that is best known for responding to environmental toxicant exposures to induce a battery of xenobiotic-metabolizing genes.

objectivesThe intent of the work reported here was to test more directly the role of the AHR in obesity and fat metabolism in lieu of exogenous toxicants.

methodsWe used two congenic mouse models that differ at the Ahr gene and encode AHRs with a 10-fold difference in signaling activity. The two mouse strains were fed either a low-fat (regular) diet or a high-fat (Western) diet.

resultsThe Western diet differentially affected body size, body fat:body mass ratios, liver size and liver metabolism, and liver mRNA and miRNA profiles. The regular diet had no significant differential effects.

conclusionsThe results suggest that the AHR plays a large and broad role in obesity and associated complications, and importantly, may provide a simple and effective therapeutic strategy to combat obesity, heart disease, and other obesity-associated illnesses.

Indexed as

Adipose TissueAnimalsBody WeightDietDietary FatsLiverMiceMice, Inbred C57BLMicroRNAsModels, AnimalObesityPolymerase Chain ReactionReceptors, Aryl HydrocarbonRNA, MessengerSignal TransductionDietary FatsMicroRNAsReceptors, Aryl HydrocarbonRNA, Messenger

Identifiers

PMID22609946
PMCPMC3440132
OpenAlexW2048391008

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.